{"id":"W2060696690","doi":"10.1016/j.lungcan.2013.11.020","title":"Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer","year":2013,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Merck Sharp and Dohme","keywords":"Medicine; Erlotinib; Internal medicine; Neutropenia; Oncology; Lung cancer; Adverse effect; Surgery; Cancer; Epidermal growth factor receptor; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002262297,0.0004329357,0.001067783,0.000146339,0.00009520655,0.00002482737,0.0002970542,0.0001076987,0.0005708982],"category_scores_gemma":[0.0000531396,0.0002698772,0.0001641382,0.0004598594,0.0001831878,0.0002151642,0.000128974,0.0004563308,0.000004706781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007136589,"about_ca_system_score_gemma":0.0003442752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005714357,"about_ca_topic_score_gemma":0.001863826,"domain_scores_codex":[0.997247,0.0001898348,0.0007124066,0.0005867099,0.0007161128,0.0005478832],"domain_scores_gemma":[0.9980309,0.0002015215,0.0005078805,0.0007205385,0.0003609029,0.0001782632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2773912,0.004462022,0.6978638,0.0005351587,0.0008956105,0.00001795597,0.007144295,0.00133556,0.001844974,0.000005092978,0.0003264945,0.008177772],"study_design_scores_gemma":[0.8903041,0.0009852032,0.09665453,0.0009962561,0.001105928,7.233725e-7,0.001571974,0.0009017686,0.006871242,0.000006985354,0.0001372718,0.0004640158],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876316,0.001929677,0.00004281231,0.0002946352,0.001312217,0.008305837,0.00005427971,0.00004602,0.0003828831],"genre_scores_gemma":[0.9952396,0.00008477559,0.0001229571,0.0002296794,0.0002914731,0.003122915,0.000009540511,0.0000962286,0.0008027866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6129129,"threshold_uncertainty_score":0.9999753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009580312840794003,"score_gpt":0.2976431150917498,"score_spread":0.2880628022509558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}